Background To discern whether hypertriglyceridemia (hyper-TG, TG >95th percentile) and hypoalphalipoproteinemia (hypoalpha, high-density lipoprotein [HDL-C] lOth percentile) are jointly transmitted in families, we studied 385 probands with marked elevations in TG or cholesterol levels (TG or cholesterol >99th percentile in a previous visit) and their 2072 first-degree relatives in the Lipid Research Clinics' Family Study. Repeat TG measurement, with exclusion crite-
.6% of first-degree relatives conjointly expressed hyper-TG and hypoalpha in contrast to only 4.1% of first-degree relatives of a proband who expressed high TG levels with normal HDL-C levels (TG >95th percentile, HDL-C >lOth percentile, n=80). Hyper-TG was expressed in 24 .2% of first-degree relatives of probands with CT.
H rypertriglyceridemia is commonly observed in postmyocardial infarction patients.1 However, its independent, direct causal relation to atherosclerotic vascular disease has been questioned.2 Acquired hypertriglyceridemia may be secondary to alcohol ingestion,3 obesity,4 high fat diets,3 diabetes mellitus,5 and immunologic disease. 6 Among plasma lipids and lipoproteins, triglyceride (TG) is an environmentally dependent parameter and thus is labile. 7 Clinical trials including the Stockholm Ischemic Heart Disease Study, 8 the Helsinki Trial,9 the Cholesterol-Lowering Angiographic Study (CLAS),10 and the more recent FATS Study" have provided some support for the notion that treatment of more than simply one lipoprotein or lipid value is beneficial in the protection against cardiovascular disease, including lowering low-density lipoprotein cholesterol (LDL-C), raising high-density lipoprotein cholesterol (HDL-C), and lowering TG.
Plasma TG concentration and HDL-C levels have been found generally to be inverse parameters.12 Elevations in TG concentration associated with an increase in the number of very-low-density lipoprotein (VLDL) particles result in a remodeling of the HDL particle, producing a TG-enriched and cholesterol ester-poor HDL. 13 One might speculate that the TG level is the major and most frequent basis for hypoalpha concentrations. 3 Thus, the TG level may be the critical parameter, whereas the HDL-C level is simply secondary. difference in percentages between the two groups was assessed using the Wilcoxon rank-sum test25 for each of the six traits.
Results
Of the 385 original probands (Fig 1) , 223 were excluded due to TG <95th percentile on the second visit. Of the remaining 162 probands, 82 had CT and had a total of 458 first-degree relatives, resulting in an average family size of 6.6 (including the proband). The balance of 80 probands had normal HDL-C with hyper-TG and had a total of 451 first-degree relatives, also resulting in an average family size of 6.6. Table 1 displays mean+SEM of age, lipoproteins, Q0, and blood pressures for the CT and normal HDL-C-hyper-TG proband groups. Because the original population was enriched for elevated TG and total cholesterol, the repeat hypertriglyceridemic population demonstrated an unanticipated elevation in total cholesterol. A reevaluation of the original 385 probands' visit 1 total cholesterol and TG levels using the LRC's age-, sex-, and race-specific percentiles indicated that 26.8% had total cholesterol >95th percentile alone, 50.4% had TG >95th percentile alone, and 22.7% had both total cholesterol and TG >95th percentile. Thus, 73.1% of these probands had visit 1 TG levels >95th percentile. Accordingly, 96% of the 162 probands (155 of 162) had both visit 1 TG >95th percentile and visit 2 TG >95th percentile. Misclassification due to the use of the preliminary visit 1 data percentiles did not have a significant effect on the results. Table 2 displays the number of proband-defined families with specific family member phenotypes. Within the two proband-defined phenotypes, ie, CT and normal HDL-C-hyper-TG, the number of families with one or more affected family members and the number of families with two or more affected family members are given for the following phenotypes: (1) hypoalpha alone, (2) hyper-TG alone, (3) hypoalpha and hyper-TG, (4) hypoalpha (combining normal TG and hyper-TG), (5) hyper-TG (combining normal HDL-C and hypoalpha), and (6) hypoalpha and/or hyper-TG. For example, 53 of the 82 families in which the proband has CT had at least 1 family member with hypoalpha, whereas 24 families had at least 2 family members with hypoalpha. Conversely, of the 80 families in which the proband has hyper-TG alone, 31 families had at least 1 family member with hypoalpha and 7 families had at least 2 family members with hypoalpha. Comparison of CT and normal HDL-C-hyper-TG proband-associated families indicates that each subgroup (hypoalpha alone, hyper-TG and hypoalpha, and hyper-TG alone) is relatively enriched in the CT proband-associated first-degree relatives (P=.0149, P=.0043, and P= .0347, respectively). Hypoalpha overall (P=.0003) and hyper-TG overall (P=.0011) are observed more frequently in CT proband-associated family members. A comparison of all HDL-C-TG abnormalities between these two groups also demonstrates a significant difference (35.3% versus 20.8%, P=.0001).
As a means of establishing whether or not the CT and normal HDL-C-hyper-TG proband groups differ with respect to family history for coronary heart disease, the percentage of probands who had ever had a heart attack and the percentage of probands whose father and/or mother had a positive family history for coronary heart disease were compared. Table 3 displays these results. n=27), the percentage with LDL-C >95th percentile were 2.4% (1 of 42) and 11.1% (3 of 27), respectively. This indirectly suggests that CT subjects had lower LDL-C values from those with hyper-TG alone. Forty-five of the 458 first-degree relatives of probands with CT had the hypoalpha-hyper-TG trait, whereas 17 of the 451 first-degree relatives of probands with normal HDL-C-hyper-TG had the hypoalpha-hyper-TG trait. The LDL-C and QI distributions do not suggest a difference between the two groups. proband-defined groups.
Discussion
We have assessed first-degree family members of probands with two types of lipoprotein profiles: (1) hyper-TG and hypoalpha and (2) hyper-TG and normal HDL-C. The data strongly suggest that elevated TG concentrations in patients do not totally determine the HDL-C concentration, a finding consistent with previous studies. 26 The family lipid-lipoprotein distribution is clearly different, depending on whether the hyper-TG proband does or does not also express hypoalpha. Furthermore, the percentage with the hypoalpha-hyper-TG trait among hypoalpha and hyper-TG family members as well as the percentage of hypoalpha and hyper-TG alone is greater in first-degree relatives of CT probands than in first-degree relatives of hyper-TG probands. The hypoalpha-hyper-TG trait exists as a unique transmissable entity or is the result of a linked transmission of both low HDL-C and high TG independently.
In the present study, the patients had extremely elevated TG levels (TG in the upper 5th percentile rather than upper 10th percentile) but in addition had values that were measured twice. This avoids the dilutional effect of regression to increased probability that hyper-TG exists. There would presumably be a higher incidence of genetic defects in this population.
We have previously reported on the random sample of the LRC Family Study, where 2.7% to 3.6% of probands demonstrated the CT defined by extreme deciles for both TG and HDL-C measured only once.27 These differences in definition of hyper-TG between the current and previous studies may explain the significant enrichment in the total average percentage of hyper-TG individuals among the family members of probands with hyper-TG alone (14.4% currently versus 9.8% previously).27 The 10.6% of CT family members of CT probands found is consistent with the 12.7% reported previously, given the TG cutoff point was more stringent in the current study. Therefore, these data suggest some interaction presumably between VLDL and HDL particles as relevant to the association of TG and HDL-C levels among generations.28 Path analysis performed on the random sample from the LRC Family Study suggests that the VLDL-HDL-C interaction is determined by factors beyond the family environment.29 This would be consistent with a genetic basis for these associations.
A substantial portion of the inverse relation between HDL-C and TG is based on a transfer of TG and cholesterol ester between the VLDL and HDL particles.30,31 Deckelbaum et a132 have indicated that as TG increases there is a continuous remodeling of the HDL particle, which would lead to a reduction in the cholesterol moiety. Sane and Nikkila33 evaluated first-degree relatives of hyper-TG probands and found that the fractional catabolic rate (FCR) of VLDL-TG was clearly reduced in these relatives, while production rates were either normal or Familial dyslipoproteinemias traditionally described such as familial combined hyperlipidemia and familial hyper-TG as well as familial hypoalphalipoproteinemia often present with phenotypes associated with TG abnormalities and/or the CT. Familial combined subjects frequently express elevated LDL-C levels, and whereas LDL-C levels >90th percentile are distributed similarly among families in both of our groups, hyper-TG-alone subjects tended to have higher calculated LDL-C levels than CT subjects. Even though these calculated LDL-C levels, according to the Friedewald equation, could be inaccurate down to TG levels of 250 mg/dL,42 this contrast in LDL-C continued to be evident when only subjects with TG levels >400 mg/dL were evaluated, ie, LDL-C more directly measured through beta quantification. Lack of apolipoprotein B data on our subjects as well as the generally modest size of our families precludes more definitive assessment of the association between CT and the previously described entities of familial hyper-TG or combined hyperlipidemia. Furthermore, the more recent description of familial dyslipidemic hypertension permits one or more of the extreme decile LDL-C, TG, and HDL-C values into the classification schema. 18 High TG levels, commonly associated with patient populations found to have cardiovascular disease, are often not statistically informative, since other measurements, notably HDL-C, are more relevant after multiple regression.2 In our population, probands with concomitant low HDL-C and high TG had more reported myocardial infarctions (5 of 82) than probands with high TG alone (0 of 80, P=.02). In addition, there was a suggestive trend (P=.09) toward more cardiovascular disease in families of CT probands. This is consistent with Framingham data, suggesting enhanced incidence of heart disease in high TG subjects who also have low HDL-C. 45 Similarly, in non-insulin-dependent diabetes, 7-year follow-up data suggested high TG as a risk predictor only in the presence of low HDL-C. 46 In contrast, an enhanced mortality in male subjects with low HDL-C-hyper-TG was no longer observed after adjustments were made for fasting plasma glucose concentrations.47 Low HDL-C-hyper-TG subjects are noted to demonstrate insulin resistance48 concurrently associated with increased body mass index. Obesity is associated with elevations in TG and reductions in HDL-C. It was noted that both proband groups had an increased Quetelet (Fig 5) , and the mean levels of QI as well as TG were higher in the CT proband group. However, distributional comparison provided no evidence for a significant difference in QI. Furthermore, even though the CT probands demonstrated a more skewed TG distribution than the hyper-TG probands, all TG values were >95th percentile. Therefore, group differences in QI and TG levels cannot totally explain the marked distinction between the family member HDL-C-TG distribution.
The independent correlation of HDL-C with cardiovascular risk49 may be the critical and relevant issue, excluding TG values as influential. However, the intricate metabolic connection between HDL and TG rich lipoproteins30 prompts speculation on some interactive effect for the development of vascular disease.43 A patient with high TG alone or low HDL-C alone may communicate a different basic mechanism and ultimate cardiovascular risk profile than one who concurrently expresses both high TG and hypoalpha.
In summary, high TG found in a clinic patient has relevance to family members. When high TG is found with low HDL-C in the proband, each of the HDL-C/TG phenotypes is enriched in the family. When high TG is noted alone in the proband, high TG and high QI are found in family members, however, the prevalence of low HDL-C is not enriched among associated family members. Therefore, the findings of high TG should prompt careful inspection of the HDL-C level since conjoined abnormalities in both HDL-C and TG tend to be associated with an enhanced risk for cardiovascular disease.
